128 related articles for article (PubMed ID: 7968018)
1. Intravenous iron-sucrose complex to reduce epoetin demand in dialysis patients.
Nyvad O; Danielsen H; Madsen S
Lancet; 1994 Nov; 344(8932):1305-6. PubMed ID: 7968018
[No Abstract] [Full Text] [Related]
2. [Changes in iron metabolism and erythropoietin requirements after the switch from ferric gluconate to iron saccharose. Is it worth the increased expense?].
Rodríguez Palomares JR; Fanlo B; Albarracín C; Junquera E
Nefrologia; 2003; 23(2):181-2. PubMed ID: 12778887
[No Abstract] [Full Text] [Related]
3. Intravenous iron in chronic kidney disease: haemoglobin change shortly after treatment of patients neither on dialysis nor on erythropoietin.
Tagboto S; Cropper L; Mostafa S; Turner J; Bailey G; Pugh-Clarke K
J Ren Care; 2008 Sep; 34(3):112-5. PubMed ID: 18786076
[TBL] [Abstract][Full Text] [Related]
4. [Treatment with intravenous iron and ferritin level].
Fernández-Gallego J; Martín MA; Sujan S; Vega E
Nefrologia; 2010; 30(3):371-2. PubMed ID: 20514109
[No Abstract] [Full Text] [Related]
5. Low incidence of adverse events following 90-minute and 3-minute infusions of intravenous iron sucrose in children on erythropoietin.
Anbu AT; Kemp T; O'donnell K; Smith PA; Bradbury MG
Acta Paediatr; 2005 Dec; 94(12):1738-41. PubMed ID: 16431410
[TBL] [Abstract][Full Text] [Related]
6. [Use of venofer for iron deficiency correction in patients undergoing programmed hemodialysis].
Fesiuk AF; Mordik AI; Borisova EV; Borisov AV; Lovchinskiĭ EV
Ter Arkh; 2003; 75(8):59-61. PubMed ID: 14520854
[TBL] [Abstract][Full Text] [Related]
7. Benefits of early utilization of intravenous iron.
Vogel S
Nephrol Nurs J; 2000 Feb; 27(1):61-5. PubMed ID: 10852693
[TBL] [Abstract][Full Text] [Related]
8. Iron in the treatment of anemia in dialysis patients: an important support to erythropoietin.
Gallieni M
Int J Artif Organs; 1998 Nov; 21(11):681-6. PubMed ID: 9894741
[No Abstract] [Full Text] [Related]
9. Drug distribution and expenditure: the issue of epoetin in Italy.
La Vecchia C; Franceschi S; Apolone G
Eur J Public Health; 2003 Dec; 13(4):367. PubMed ID: 14703326
[No Abstract] [Full Text] [Related]
10. Long-term safety follow-up of a randomized trial of darbepoetin alpha and intravenous iron following autologous hematopoietic cell transplantation.
Jaspers A; Baron F; Maertens J; De Prijck B; Schots R; Bonnet C; Hafraoui K; Willems É; Servais S; Fillet G; Beguin Y
Am J Hematol; 2015 Jul; 90(7):E133-4. PubMed ID: 25802012
[No Abstract] [Full Text] [Related]
11. Epoetin alfa and intravenous iron sucrose to treat severe anemia in a patient with chronic radiation enteropathy: a case report.
Séronie-Vivien S; Mourey L; Tohfe M; Bugat R
Med Oncol; 2003; 20(3):301-6. PubMed ID: 14514981
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin, an update, and where to in the future?
Sulková S
EDTNA ERCA J; 1998; 24(3):30-2, 35. PubMed ID: 10392076
[TBL] [Abstract][Full Text] [Related]
13. Trends in intravenous iron use among dialysis patients in the United States (1994-2002).
St Peter WL; Obrador GT; Roberts TL; Collins AJ
Am J Kidney Dis; 2005 Oct; 46(4):650-60. PubMed ID: 16183420
[TBL] [Abstract][Full Text] [Related]
14. Safety of Intravenous Iron in Hemodialysis: Longer-term Comparisons of Iron Sucrose Versus Sodium Ferric Gluconate Complex.
Winkelmayer WC; Goldstein BA; Mitani AA; Ding VY; Airy M; Mandayam S; Chang TI; Brookhart MA; Fishbane S
Am J Kidney Dis; 2017 Jun; 69(6):771-779. PubMed ID: 28063734
[TBL] [Abstract][Full Text] [Related]
15. Effect of correction of anemia with erythropoietin and intravenous iron in resistant heart failure in octogenarians.
Silverberg DS; Wexler D; Blum M; Schwartz D; Keren G; Sheps D; Iaina A
Isr Med Assoc J; 2003 May; 5(5):337-9. PubMed ID: 12811950
[TBL] [Abstract][Full Text] [Related]
16. Review of available intravenous iron preparations in hemodialysis.
Palmer K; Cameron K; Battistella M
CANNT J; 2013; 23(2):51-4; quiz 55-6. PubMed ID: 24069699
[No Abstract] [Full Text] [Related]
17. [Current recommendations for the treatment of iron deficiency anemia].
Schaefer RM; Huch R; Krafft A;
Rev Med Suisse; 2007 Apr; 3(105):874-80. PubMed ID: 17514929
[TBL] [Abstract][Full Text] [Related]
18. Low-dose intravenous iron administration in chronic hemodialysis patients treated with recombinant human erythropoietin.
Harmankaya O; Eran A
Ren Fail; 2002 Mar; 24(2):245-7. PubMed ID: 12071600
[TBL] [Abstract][Full Text] [Related]
19. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.
Drüeke TB; Bárány P; Cazzola M; Eschbach JW; Grützmacher P; Kaltwasser JP; Macdougall IC; Pippard MJ; Shaldon S; van Wyck D
Clin Nephrol; 1997 Jul; 48(1):1-8. PubMed ID: 9247771
[TBL] [Abstract][Full Text] [Related]
20. Blood conservation in the critically ill.
Thomas J; Martinez A
Am J Health Syst Pharm; 2007 Aug; 64(16 Suppl 11):S11-8. PubMed ID: 17687066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
